DOW JONES22,327.48+690.70 3.19%
S&P 5002,626.65+85.18 3.35%
NASDAQ7,774.15+271.77 3.62%

Cantor Fitzgerald Reiterates Overweight on PTC Therapeutics, Raises Price Target to $86

Cantor Fitzgerald analyst Alethia Young reiterates PTC Therapeutics (NASDAQ:PTCT) with a Overweight and raises the price target from $81 to $86.

Benzinga · 03/03/2020 11:36

Cantor Fitzgerald analyst Alethia Young reiterates PTC Therapeutics (NASDAQ:PTCT) with a Overweight and raises the price target from $81 to $86.